Question 1

How many institutions own IRD stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own IRD shares is 46, representing 27.76% of the company's common stock.

Question 2

Who are the major shareholders selling Opus Genetics, Inc. stock?

Accepted Answer

N/A, in the last quarter, reduced its stake in IRD by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the IRD shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned IRD shares holding by N/A last quarter which brought its holding to - shares worth -.

Question 3

Investors who are buying IRD stock?

Accepted Answer

As per its latest 13F filing, N/A increased its stake in IRD by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of IRD to its portfolio, raising its holding to - shares of worth -. N/A also increased its IRD shares holding by N/A which brought its holding to - shares worth -.

Question 4

IRD's major insiders: who are they?

Accepted Answer

The insider with the most stakes in IRD is Foundation Fighting Blindness Retinal Degeneration Fund , See Remarks at the company. Additionally, IRD stock is highly held by Chief Executive Officer Magrath George and President YERXA BENJAMIN R among others.

Question 5

Did an insider recently sell IRD stock?

Accepted Answer

Company executives, directors, and other insiders own 21.58% percent of Opus Genetics, Inc.'s stock. Within the last six months, there have been 1 transaction(s) in which IRD insiders have sold stock, totaling 4M shares. Insiders that have sold shares include FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND.

Question 6

Which insider recently purchased IRD stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Opus Genetics, Inc. insiders have bought stock, totalling 0 shares

Question 7

How much of IRD does insiders own?

Accepted Answer

Around 5.49M Opus Genetics, Inc. shares are held by insiders, which represents about 21.58% of IRD stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

IRD See Remarks, Foundation Fighting Blindness Retinal Degeneration Fund holds the largest portfolio of the company's shares. IRD shares owned by Foundation total nearly 5.49 million.

Question 9

Which institution holds the most shares in IRD?

Accepted Answer

N/A is the largest institutional owner in IRD which holds - shares worth - or N/A of the total IRD shares outstanding followed by N/A with ownership of - shares representing N/A of the IRD ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Question 10

Is Opus Genetics, Inc. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the IRD is concerned, it is a stock which is  optionable.

Question 11

Is there a short position on IRD's shares?

Accepted Answer

Number of IRD shares short is 255.25K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding IRD shares are there?

Accepted Answer

As of today, 59.91M shares of IRD are outstanding.

Question 13

Is there many float in IRD stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, IRD has 30.28M shares in float.

Question 14

IRD short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for IRD is 1.05.

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 09, 2025	FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND	SALE	2.15	4M	8.6M	5.49M
Dec 26, 2024	MAGRATH GEORGE	PURCHASE	0.98	100K	97.6K	599.15K
Nov 21, 2024	YERXA BENJAMIN R	PURCHASE	0.98	10K	9.83K	342.8K
Nov 18, 2024	MAGRATH GEORGE	PURCHASE	1.02	9.71K	9.94K	492.95K
Nov 15, 2024	MAGRATH GEORGE	PURCHASE	1.01	90.29K	91.21K	483.24K

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Dec 09, 2025	FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND	SALE	2.15	4M	8.6M	5.49M
Dec 26, 2024	MAGRATH GEORGE	PURCHASE	0.98	100K	97.6K	599.15K
Nov 21, 2024	YERXA BENJAMIN R	PURCHASE	0.98	10K	9.83K	342.8K
Nov 18, 2024	MAGRATH GEORGE	PURCHASE	1.02	9.71K	9.94K	492.95K
Nov 15, 2024	MAGRATH GEORGE	PURCHASE	1.01	90.29K	91.21K	483.24K

IRD Stock Ownership Breakdown

Opus Genetics

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Insider Transaction Summary (6 Months)

Frequently Asked Questions